Genes Discovered Influence Risk of Developing Leprosy
By LabMedica International staff writers Posted on 25 Mar 2015 |
Image: Histopathology of tuberculoid leprosy in a skin section (Photo courtesy Dr. D.S. Ridley, Wellcome Images).
Leprosy, a chronic dermatological and neurological disease, is caused by infection with Mycobacterium leprae, and its manifestation, progression and prognosis are strongly associated with the proficiency of the patient's immune system.
The ability to predict the risk of contracting leprosy can help guide decisions made by public healthcare policymakers when drafting preventative measures for high-risk medical staff working in close contact with leprosy patients.
Scientists at the Genome Institute of Singapore (A*STAR, Singapore) conducted a three-stage genome-wide association studies (GWAS) of leprosy in the Chinese population. The genome-wide discovery analysis (stage 1) involved two independent data sets: a previously published GWAS data set of 706 leprosy cases, 1,225 healthy controls and 4,362 individuals with immune-related diseases as population controls from northern China of Chinese Han descent and a new unpublished data set of 842 leprosy cases and 925 controls from northern and southern China.
The second independent study was genotyped using Human 660K-Quad BeadChips (Illumina; San Diego, CA, USA). The scientists discovered six new susceptibility loci, and further gene prioritization analysis of these loci implicated Basic Leucine Zipper Transcription Factor, ATF-Like 3 (BATF3), Coiled-Coil Domain Containing 88B (CCDC88B) and Class II, major histocompatibility complex, transactivator-Suppressor of cytokine signaling 1 (CIITA-SOCS1) as new susceptibility genes for leprosy. They found the same genes linked to leprosy susceptibility also affect the level of aggression expressed by the immune system observed in autoimmune and inflammatory diseases. A person with an overly-aggressive immune system may have a good defense against infection, but stands a higher risk of developing autoimmune diseases where one's own white blood cells attack healthy cells that can lead to death in severe cases.
Jianjun Liu, PhD, a professor and lead author of the study, said, “Although commonly viewed as a medieval affliction, leprosy remains a major health problem in developing countries, claiming over 200,000 new patients worldwide annually with two to three million people permanently disabled. With the discovery of more gene variants that affect the risk of developing leprosy, we can develop better diagnostic, treatment and preventive strategies to one day eradicate leprosy permanently.” The study was published online on February 3, 2015, in the journal Nature Genetics.
Related Links:
Genome Institute of Singapore
Illumina
The ability to predict the risk of contracting leprosy can help guide decisions made by public healthcare policymakers when drafting preventative measures for high-risk medical staff working in close contact with leprosy patients.
Scientists at the Genome Institute of Singapore (A*STAR, Singapore) conducted a three-stage genome-wide association studies (GWAS) of leprosy in the Chinese population. The genome-wide discovery analysis (stage 1) involved two independent data sets: a previously published GWAS data set of 706 leprosy cases, 1,225 healthy controls and 4,362 individuals with immune-related diseases as population controls from northern China of Chinese Han descent and a new unpublished data set of 842 leprosy cases and 925 controls from northern and southern China.
The second independent study was genotyped using Human 660K-Quad BeadChips (Illumina; San Diego, CA, USA). The scientists discovered six new susceptibility loci, and further gene prioritization analysis of these loci implicated Basic Leucine Zipper Transcription Factor, ATF-Like 3 (BATF3), Coiled-Coil Domain Containing 88B (CCDC88B) and Class II, major histocompatibility complex, transactivator-Suppressor of cytokine signaling 1 (CIITA-SOCS1) as new susceptibility genes for leprosy. They found the same genes linked to leprosy susceptibility also affect the level of aggression expressed by the immune system observed in autoimmune and inflammatory diseases. A person with an overly-aggressive immune system may have a good defense against infection, but stands a higher risk of developing autoimmune diseases where one's own white blood cells attack healthy cells that can lead to death in severe cases.
Jianjun Liu, PhD, a professor and lead author of the study, said, “Although commonly viewed as a medieval affliction, leprosy remains a major health problem in developing countries, claiming over 200,000 new patients worldwide annually with two to three million people permanently disabled. With the discovery of more gene variants that affect the risk of developing leprosy, we can develop better diagnostic, treatment and preventive strategies to one day eradicate leprosy permanently.” The study was published online on February 3, 2015, in the journal Nature Genetics.
Related Links:
Genome Institute of Singapore
Illumina
Latest Molecular Diagnostics News
- Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods
- Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection
- Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes
- First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening
- Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis
- AI Technology-Based Blood Test Identifies Lung Cancer Earlier
- Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse
- Prenatal Testing Offers Window for Finding Mother’s Cancer Risk
- New Molecular Test Detects More Cervical Cancer Cases
- New Panel Quickly and Accurately Identifies 16 Common Gastrointestinal Pathogens
- New DNA Testing Method Offers Faster and More Accurate Pathogen Identification
- Precise Cancer Detection Method as Quick and Easy as Blood Test
- DNA Spit Test More Accurate At Identifying Future Prostate Cancer Risk
- Novel Method Combining Nano Informatics and AI Paves Way for Cancer Blood Tests
- Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes
- New Assay Detects Heart Failure Biomarker in Less than 11 Minutes